|
|
Neurodevelopmental Effects of Prenatal Exposure to Maternal Drinking, Smoking and Adverse Psychosocial Factors: Deep Phenotyping of Infant CNS and ANS Function |
| 1R01AA029159-01A1 |
|
NIAAA |
2022 |
|
|
Maternal mediators of fetal growth restriction linked to prenatal alcohol exposure |
| 1R01AA029594-01A1 |
|
NIAAA |
2022 |
|
|
The role of mitochondrial stress response in alcohol-mediated neurotoxicity |
| 1R21AA029811-01A1 |
|
NIAAA |
2022 |
|
|
Cardiovascular disease in fetal alcohol spectrum disorder |
| 1U01AA030185-01 |
|
NIAAA |
2022 |
|
|
Project 2: Prenatal Alcohol Exposure (PAE) and Fetal Alcohol Spectrum Disorder (FASD) |
| 1U54AA030451-01 |
|
NIAAA |
2022 |
|
|
Prenatal Alcohol Exposure and Fetal Alcohol Spectrum Disorder |
| 1U54AA030463-01 |
|
NIAAA |
2022 |
|
|
Administrative Resource of the CIFASD |
| 2U24AA014811-19 |
|
NIAAA |
2022 |
|
|
Touchscreen-compatible, real-time electrochemical sensing of SARS-CoV-2 |
| 4U01AA029316-02 |
|
NIAAA |
2022 |
|
|
Assessing Stable Characteristics of Endocrine Function Among Boys and Girls with Prenatal Alcohol Exposure as a Novel Clinical Tool |
| 5K01AA026889-05 |
|
NIAAA |
2022 |
|
|
Identifying and protecting alcohol-sensitive epigenetic changes in congenital heart disease |
| 5K08AA028845-02 |
|
NIAAA |
2022 |